Chinese english Germany Korea

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

化学構造式
2088771-61-1
CAS番号.
2088771-61-1
化学名:
别名:
英語名:
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
英語别名:
Impurity FP-B;Sitagliptin-17;Sitagliptin Impurity 20;Sitagliptin FP Impurity B;Sitagliptin Impurity FP-B;Sitagliptin Triazecine Impurity;(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl);Sitagliptin FP Impurity B/ Sitagliptin Triazecine Analog;(R)-Sitagliptin Tablets EP Impurity FP-B ((R)-Sitagliptin Triazecine Analog);(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
CBNumber:
CB23371367
化学式:
C16H13F6N5O2
分子量:
421.3
MOL File:
2088771-61-1.mol

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione 物理性質

融点 :
>189°C (dec.)
比重(密度) :
1.67±0.1 g/cm3(Predicted)
貯蔵温度 :
-20°C Freezer, Under inert atmosphere
溶解性:
DMSO（微量）、メタノール（微量）
酸解離定数(Pka):
12.02±0.40(Predicted)
外見 :
個体
色:
ホワイトからオフホワイト
InChI:
InChI=1S/C16H13F6N5O2/c17-9-6-11(19)10(18)4-7(9)3-8-5-12(28)23-1-2-27-13(14(29)24-8)25-26-15(27)16(20,21)22/h4,6,8H,1-3,5H2,(H,23,28)(H,24,29)/t8-/m1/s1
InChIKey:
CJUCSNDPMOGZTM-MRVPVSSYSA-N
SMILES:
N1[C@H](CC2=CC(F)=C(F)C=C2F)CC(=O)NCCN2C(C(F)(F)F)=NN=C2C1=O

安全性情報

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione 化学特性,用途語,生産方法

使用

(10R)-Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione 上流と下流の製品情報

原材料

準備製品

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione 生産企業

Global( 61)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
BOC Sciences
+16314854226
 inquiry@bocsci.com United States 19743 58
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Finetech Industry Limited 		+86-27-87465837 +8618971612321
 info@finetechnology-ind.com China 9634 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3149 58
sgtlifesciences pvt ltd 		+8617013299288
 dj@sgtlifesciences.com China 12382 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Zibo Hangyu Biotechnology Development Co., Ltd 		+86-0533-2185556 +8617865335152
 Mandy@hangyubiotech.com China 11013 58
Shanghai Payne Pharmaceutical Technology Co.Ltd 		021-58123769 18678586262
 info@paynepharm.com China 1354 58
ShenZhen Davoos Tech Ltd 0752-5555973 13923768523
 95372103@qq.com China 670 58
Ji'nan tengbang pharmaceutical science and Technology Co., Ltd. 0531-88769236 15688889648
 2685550793@qq.com China 122 58

2088771-61-1()キーワード:

3-(トリフルオロメチル)-5,6,7,8-テトラヒドロ-[1,2,4]トリアゾロ[4,3-a]ピラジン塩酸塩 3-オキソ-4-(2,4,5-トリフルオロフェニル)ブタン酸メチル シタグリプチン シタグリプチンリン酸塩 N-Boc-シタグリプチン 3-アミノ-4-(2,4,5-トリフルオロフェニル)ブタン酸メチル N-[(2Z)-ピペラジン-2-イリデン]-2,2,2-トリフルオロアセトヒドラジド 2,5-ジフルオロベンゼン酢酸 2,4-ジフルオロフェニル酢酸 トリフルオロ酢酸エチル 3,4-ジフルオロフェニル酢酸 2,4,5-トリフルオロフェニル酢酸 2,3,5-トリフルオロフェニル酢酸 3-([(TERT-ブチルトキシ)カルボニル]アミノ)-4-(2,4-ジフルオロフェニル)ブタン酸 BOC-(R)-3-アミノ-4-(3,4-ジフルオロフェニル)酪酸 1-(トリフルオロアセチル)-2-(クロロアセチル)ヒドラジン 5-[1-ヒドロキシ-2-(2,4,5-トリフルオロフェニル)エチリデン]-2,2-ジメチル-1,3-ジオキサン-4,6-ジオン りん酸ENT-シタグリプチン
  • 2088771-61-1
  • Impurity FP-B
  • Sitagliptin Impurity 20
  • Sitagliptin-17
  • Sitagliptin FP Impurity B
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)
  • Sitagliptin impurity 6/Sitagliptin FP Impurity B/Sitagliptin Triazecine Analog/10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro [1,2,4] triazolo [3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • 1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-, (10R)-
  • (10R)?- 6,?7,?10,?11-?Tetrahydro-?3-?(trifluoromethyl)?-?10-?[(2,?4,?5-?trifluorophenyl)?methyl]?-1,?2,?4-?triazolo[3,?4-?c]?[1,?4,?7]?triazecine-?8,?12(5H,?9H)?-?dione
  • Sitagliptin FP Impurity B/ Sitagliptin Triazecine Analog
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • Sitagliptin Impurity FP-B
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione? (Sitagliptin Impurity）
  • Sitagliptin Triazecine Impurity
  • (R)-Sitagliptin Tablets EP Impurity FP-B ((R)-Sitagliptin Triazecine Analog)
Copyright 2017 © ChemicalBook. All rights reserved